Improvement of neuronal bioenergetics by neurosteroids: Implications for age-related neurodegenerative disorders

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 12, 2014, Pages 2427-2438

  Grimm, Amandine ^a,b,c   Schmitt, Karen ^a,b   Lang, Undine E ^b   Mensah Nyagan, Ayikoe Guy ^c   Eckert, Anne ^a,b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Bioenergetics; Mitochondria; Neurosteroid; Redox homeostasis

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; ADENOSINE TRIPHOSPHATE; ANDROGEN RECEPTOR ANTAGONIST; ANDROSTANEDIOL; ESTRADIOL; ESTRONE; HORMONE RECEPTOR BLOCKING AGENT; MANGANESE SUPEROXIDE DISMUTASE; MIFEPRISTONE; MITOCHONDRIAL REACTIVE OXYGEN SPECIES; NEUROSTEROID; PRASTERONE; PROGESTERONE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; TESTOSTERONE; UNCLASSIFIED DRUG; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ELTANOLONE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; BASAL MITOCHONDRIAL RESPIRATION; BIOENERGY; BRAIN CELL; BRAIN CELL CULTURE; BRAIN FUNCTION; CELL DEATH; CELL ENERGY; CELL PROLIFERATION; CELL RESPIRATION; CELL VIABILITY; DEGENERATIVE DISEASE; EMBRYO; ENZYME ACTIVITY; GENETIC REGULATION; GLYCOLYSIS; HOMEOSTASIS; HUMAN; HUMAN CELL; HYPERPOLARIZATION; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MOUSE; NERVE CELL; NEUROBLASTOMA CELL; NEURONAL BIOENERGETIC; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PRIMARY CELL CULTURE; PROTON MOTIVE FORCE; UPREGULATION; AGING; ANIMAL; CELL CULTURE; DOSE RESPONSE; DRUG EFFECTS; ENERGY METABOLISM; METABOLISM; MITOCHONDRION; PHYSIOLOGY; TUMOR CELL LINE;

ADENOSINE TRIPHOSPHATE; AGING; ANDROSTANE-3,17-DIOL; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; DEHYDROEPIANDROSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENERGY METABOLISM; ESTRADIOL; ESTRONE; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MITOCHONDRIA; NEURODEGENERATIVE DISEASES; NEURONS; NEUROTRANSMITTER AGENTS; OXYGEN CONSUMPTION; PREGNANOLONE; PROGESTERONE; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; TESTOSTERONE;

EID: 84910044705     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.09.013     Document Type: Article

References (64)

1. Shulman R.G., Rothman D.L., Behar K.L., Hyder F. Energetic basis of brain activity: implications for neuroimaging. Trends Neurosci. 2004, 27:489-495.
2. Yin F., Boveris A., Cadenas E. Antioxid. Redox Signal. 2014, 20:353-371.
3. Mattson M.P., Gleichmann M., Cheng A. Mitochondria in neuroplasticity and neurological disorders. Neuron 2008, 60:748-766.
4. Scheffler I.E. Mitochondrion 2001, 1:3-31.
5. Knott A.B., Perkins G., Schwarzenbacher R., Bossy-Wetzel E. Mitochondrial fragmentation in neurodegeneration. Nat. Rev. Neurosci. 2008, 9:505-518.
6. Leuner K., Muller W.E., Reichert A.S. From mitochondrial dysfunction to amyloid beta formation: novel insights into the pathogenesis of Alzheimer's disease. Mol. Neurobiol. 2012, 46:186-193.
7. Muller W.E., Eckert A., Kurz C., Eckert G.P., Leuner K. Mitochondrial dysfunction: common final pathway in brain aging and Alzheimer's disease-therapeutic aspects. Mol. Neurobiol. 2010, 41:159-171.
8. Reddy P.H., Tripathi R., Troung Q., Tirumala K., Reddy T.P., Anekonda V., Shirendeb U.P., Calkins M.J., Reddy A.P., Mao P., Manczak M. Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics. Biochim. Biophys. Acta 2012, 1822:639-649.
9. Rhein V., Song X., Wiesner A., Ittner L.M., Baysang G., Meier F., Ozmen L., Bluethmann H., Drose S., Brandt U., Savaskan E., Czech C., Gotz J., Eckert A. Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:20057-20062.
10. Schmitt K., Grimm A., Kazmierczak A., Strosznajder J.B., Gotz J., Eckert A. Insights into mitochondrial dysfunction: aging, amyloid-beta, and tau-A deleterious trio. Antioxid. Redox Signal. 2012, 16:1456-1466.
11. Corpechot C., Robel P., Axelson M., Sjovall J., Baulieu E.E. Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc. Natl. Acad. Sci. U. S. A. 1981, 78:4704-4707.
12. Mensah-Nyagan A.G., Do-Rego J.L., Beaujean D., V.Luu-The, Pelletier G., Vaudry H. Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system. Pharmacol. Rev. 1999, 51:63-81.
13. Patte-Mensah C., Kibaly C., Boudard D., Schaeffer V., Begle A., Saredi S., Meyer L., Mensah-Nyagan A.G. Neurogenic pain and steroid synthesis in the spinal cord. J. Mol. Neurosci. 2006, 28:17-31.
14. Brown R.C., Han Z., Cascio C., Papadopoulos V. Oxidative stress-mediated DHEA formation in Alzheimer's disease pathology. Neurobiol. Aging 2003, 24:57-65.
15. Caruso D., Barron A.M., Brown M.A., Abbiati F., Carrero P., Pike C.J., Garcia-Segura L.M., Melcangi R.C. Age-related changes in neuroactive steroid levels in 3xTg-AD mice. Neurobiol. Aging 2013, 34:1080-1089.
16. Smith C.D., Wekstein D.R., Markesbery W.R., Frye C.A. 3alpha,5alpha-THP: a potential plasma neurosteroid biomarker in Alzheimer's disease and perhaps non-Alzheimer's dementia. Psychopharmacology (Berl) 2006, 186:481-485.
17. Schumacher M., Weill-Engerer S., Liere P., Robert F., Franklin R.J., Garcia-Segura L.M., Lambert J.J., Mayo W., Melcangi R.C., Parducz A., Suter U., Carelli C., Baulieu E.E., Akwa Y. Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog. Neurobiol. 2003, 71:3-29.
18. Schaeffer V., Meyer L., Patte-Mensah C., Eckert A., Mensah-Nyagan A.G. Dose-dependent and sequence-sensitive effects of amyloid-beta peptide on neurosteroidogenesis in human neuroblastoma cells. Neurochem. Int. 2008, 52:948-955.
19. Schaeffer V., Patte-Mensah C., Eckert A., Mensah-Nyagan A.G. Modulation of neurosteroid production in human neuroblastoma cells by Alzheimer's disease key proteins. J. Neurobiol. 2006, 66:868-881.
20. Lim Y.A., Grimm A., Giese M., Mensah-Nyagan A.G., Villafranca J.E., Ittner L.M., Eckert A., Gotz J. Inhibition of the mitochondrial enzyme ABAD restores the amyloid-beta-mediated deregulation of estradiol. PLoS One 2011, 6:e28887.
21. Grimm A., Lim Y.A., Mensah-Nyagan A.G., Gotz J., Eckert A. Alzheimer's disease, oestrogen and mitochondria: an ambiguous relationship. Mol. Neurobiol. 2012, 46:151-160.
22. Garcia-Segura L.M., Azcoitia I., DonCarlos L.L. Neuroprotection by estradiol. Prog. Neurobiol. 2001, 63:29-60.
23. Nilsen J., Irwin R.W., Gallaher T.K., Brinton R.D. Estradiol in vivo regulation of brain mitochondrial proteome. J. Neurosci. 2007, 27:14069-14077.
24. Yao J., Irwin R., Chen S., Hamilton R., Cadenas E., Brinton R.D. Ovarian hormone loss induces bioenergetic deficits and mitochondrial beta-amyloid. Neurobiol. Aging 2012, 33:1507-1521.
25. Rosario E.R., Chang L., Head E.H., Stanczyk F.Z., Pike C.J. Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease. Neurobiol. Aging 2011, 32:604-613.
26. Klein C., Patte-Mensah C., Taleb O., Bourguignon J.J., Schmitt M., Bihel F., Maitre M., Mensah-Nyagan A.G. The neuroprotector kynurenic acid increases neuronal cell survival through neprilysin induction. Neuropharmacology 2013, 70:254-260.
27. Rhein V., Baysang G., Rao S., Meier F., Bonert A., Muller-Spahn F., Eckert A. Amyloid-beta leads to impaired cellular respiration, energy production and mitochondrial electron chain complex activities in human neuroblastoma cells. Cell. Mol. Neurobiol. 2009, 29:1063-1071.
28. Hanson G.T., Aggeler R., Oglesbee D., Cannon M., Capaldi R.A., Tsien R.Y., Remington S.J. Investigating mitochondrial redox potential with redox-sensitive green fluorescent protein indicators. J. Biol. Chem. 2004, 279:13044-13053.
29. Grassi D., Bellini M.J., Acaz-Fonseca E., Panzica G., Garcia-Segura L.M. Estradiol and testosterone regulate arginine-vasopressin expression in SH-SY5Y human female neuroblastoma cells through estrogen receptors-alpha and -beta. Endocrinology 2013, 154:2092-2100.
30. Takahashi K., Piao S., Yamatani H., Du B., Yin L., Ohta T., Kawagoe J., Takata K., Tsutsumi S., Kurachi H. Estrogen induces neurite outgrowth via Rho family GTPases in neuroblastoma cells. Mol. Cell. Neurosci. 2011, 48:217-224.
31. Camporez J.P., Akamine E.H., Davel A.P., Franci C.R., Rossoni L.V., Carvalho C.R. Dehydroepiandrosterone protects against oxidative stress-induced endothelial dysfunction in ovariectomized rats. J. Physiol. 2011, 589:2585-2596.
32. Irwin R.W., Yao J., Hamilton R.T., Cadenas E., Brinton R.D., Nilsen J. Progesterone and estrogen regulate oxidative metabolism in brain mitochondria. Endocrinology 2008, 149:3167-3175.
33. Irwin R.W., Yao J., J.To, Hamilton R.T., Cadenas E., Brinton R.D. Selective oestrogen receptor modulators differentially potentiate brain mitochondrial function. J. Neuroendocrinol. 2012, 24:236-248.
34. Meyer L., Patte-Mensah C., Taleb O., Mensah-Nyagan A.G. Neurosteroid 3alpha-androstanediol efficiently counteracts paclitaxel-induced peripheral neuropathy and painful symptoms. PLoS One 2013, 8:e80915.
35. Singh C., Liu L., Wang J.M., Irwin R.W., Yao J., Chen S., Henry S., Thompson R.F., Brinton R.D. Allopregnanolone restores hippocampal-dependent learning and memory and neural progenitor survival in aging 3xTgAD and nonTg mice. Neurobiol. Aging 2012, 33:1493-1506.
36. Dimroth P., Kaim G., Matthey U. Crucial role of the membrane potential for ATP synthesis by F(1)F(o) ATP synthases. J. Exp. Biol. 2000, 203:51-59.
37. Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
38. Hosie A.M., Wilkins M.E., Smart T.G. Neurosteroid binding sites on GABA(A) receptors. Pharmacol. Ther. 2007, 116:7-19.
39. Korshunov S.S., Skulachev V.P., Starkov A.A. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett. 1997, 416:15-18.
40. Turrens J.F. Mitochondrial formation of reactive oxygen species. J. Physiol. 2003, 552:335-344.
41. Lu S.F., McKenna S.E., Cologer-Clifford A., Nau E.A., Simon N.G. Androgen receptor in mouse brain: sex differences and similarities in autoregulation. Endocrinology 1998, 139:1594-1601.
42. Morissette M., Le Saux M., D'Astous M., Jourdain S., Al Sweidi S., Morin N., Estrada-Camarena E., Mendez P., Garcia-Segura L.M., Di Paolo T. Contribution of estrogen receptors alpha and beta to the effects of estradiol in the brain. J. Steroid Biochem. Mol. Biol. 2008, 108:327-338.
43. Wagner C.K., Pfau J.L., De Vries G.J., Merchenthaler I.J. Sex differences in progesterone receptor immunoreactivity in neonatal mouse brain depend on estrogen receptor alpha expression. J. Neurobiol. 2001, 47:176-182.
44. Frye C.A., Koonce C.J., Walf A.A. Novel receptor targets for production and action of allopregnanolone in the central nervous system: a focus on pregnane xenobiotic receptor. Front. Cell. Neurosci. 2014, 8:106.
45. Panzica G.C., Balthazart J., Frye C.A., Garcia-Segura L.M., Herbison A.E., Mensah-Nyagan A.G., McCarthy M.M., Melcangi R.C. Milestones on steroids and the nervous system: 10years of basic and translational research. J. Neuroendocrinol. 2012, 24:1-15.
46. Pike C.J., Carroll J.C., Rosario E.R., Barron A.M. Protective actions of sex steroid hormones in Alzheimer's disease. Front. Neuroendocrinol. 2009, 30:239-258.
47. Brookmeyer R., Johnson E., Ziegler-Graham K., Arrighi H.M. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 2007, 3:186-191.
48. Borras C., Gambini J., Lopez-Grueso R., Pallardo F.V., Vina J. Direct antioxidant and protective effect of estradiol on isolated mitochondria. Biochim. Biophys. Acta 2010, 1802:205-211.
49. Psarra A.M., Solakidi S., Sekeris C.E. The mitochondrion as a primary site of action of steroid and thyroid hormones: presence and action of steroid and thyroid hormone receptors in mitochondria of animal cells. Mol. Cell. Endocrinol. 2006, 246:21-33.
50. Rettberg J.R., Yao J., Brinton R.D. Estrogen: a master regulator of bioenergetic systems in the brain and body. Front. Neuroendocrinol. 2014, 35:8-30.
51. Holmes S., Abbassi B., Su C., Singh M., Cunningham R.L. Oxidative stress defines the neuroprotective or neurotoxic properties of androgens in immortalized female rat dopaminergic neuronal cells. Endocrinology 2013, 154:4281-4292.
52. Vasconsuelo A., Milanesi L., Boland R. Actions of 17beta-estradiol and testosterone in the mitochondria and their implications in aging. Ageing Res. Rev. 2013, 12:907-917.
53. Frye C.A., Edinger K.L., Lephart E.D., Walf A.A. 3alpha-Androstanediol, but not testosterone, attenuates age-related decrements in cognitive, anxiety, and depressive behavior of male rats. Front. Aging Neurosci. 2010, 2:15.
54. Frye C.A., Walf A.A. Progesterone reduces depression-like behavior in a murine model of Alzheimer's disease. Age 2009, 31:143-153.
55. Schule C., Nothdurfter C., Rupprecht R. The role of allopregnanolone in depression and anxiety. Prog. Neurobiol. 2014, 113:79-87.
56. Deniselle M.C., Carreras M.C., Garay L., Gargiulo-Monachelli G., Meyer M., Poderoso J.J., De Nicola A.F. Progesterone prevents mitochondrial dysfunction in the spinal cord of wobbler mice. J. Neurochem. 2012, 122:185-195.
57. Carver C.M., Reddy D.S. Neurosteroid interactions with synaptic and extrasynaptic GABA(A) receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability. Psychopharmacology (Berl) 2013, 230:151-188.
58. Webb S.J., Geoghegan T.E., Prough R.A., Michael Miller K.K. The biological actions of dehydroepiandrosterone involves multiple receptors. Drug Metab. Rev. 2006, 38:89-116.
59. Chua C.K., Henderson V.W., Dennerstein L., Ames D., Szoeke C. Dehydroepiandrosterone sulfate and cognition in midlife, post-menopausal women. Neurobiol. Aging 2014, 35:1654-1655.
60. Patel M.A., Katyare S.S. Treatment with dehydroepiandrosterone (DHEA) stimulates oxidative energy metabolism in the cerebral mitochondria. A comparative study of effects in old and young adult rats. Neurosci. Lett. 2006, 402:131-136.
61. Wispe J.R., Clark J.C., Burhans M.S., Kropp K.E., Korfhagen T.R., Whitsett J.A. Synthesis and processing of the precursor for human mangano-superoxide dismutase. Biochim. Biophys. Acta 1989, 994:30-36.
62. Razmara A., Duckles S.P., Krause D.N., Procaccio V. Estrogen suppresses brain mitochondrial oxidative stress in female and male rats. Brain Res. 2007, 1176:71-81.
63. Henderson V.W., Brinton R.D. Menopause and mitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy. Prog. Brain Res. 2010, 182:77-96.
64. Reddy P.H. Mitochondrial dysfunction in aging and Alzheimer's disease: strategies to protect neurons. Antioxid. Redox Signal. 2007, 9:1647-1658.